These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3059670)

  • 1. Present and future applications of vaccinia virus as a vector.
    Hruby DE
    Vet Parasitol; 1988 Sep; 29(2-3):281-92. PubMed ID: 3059670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus.
    Berinstein A; Tami C; Taboga O; Smitsaart E; Carrillo E
    Vaccine; 2000 Apr; 18(21):2231-8. PubMed ID: 10717342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus: a tool for research and vaccine development.
    Moss B
    Science; 1991 Jun; 252(5013):1662-7. PubMed ID: 2047875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice.
    Andrew ME
    Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():339-41. PubMed ID: 2613281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus vectors: new strategies for producing recombinant vaccines.
    Hruby DE
    Clin Microbiol Rev; 1990 Apr; 3(2):153-70. PubMed ID: 2187593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation.
    Kalus RM; Kantor JA; Gritz L; Gómez Yafal A; Mazzara GP; Schlom J; Hodge JW
    Vaccine; 1999 Feb; 17(7-8):893-903. PubMed ID: 10067696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vaccinia viruses and the development of immunization strategies using influenza virus.
    Doherty PC; Allan W; Boyle DB; Coupar BE; Andrew ME
    J Infect Dis; 1989 Jun; 159(6):1119-22. PubMed ID: 2786041
    [No Abstract]   [Full Text] [Related]  

  • 8. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.
    Viner KM; Girgis N; Kwak H; Isaacs SN
    Virology; 2007 May; 361(2):356-63. PubMed ID: 17188733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.
    Moss B
    Dev Biol Stand; 1994; 82():55-63. PubMed ID: 7958483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.
    Panicali D; Davis SW; Weinberg RL; Paoletti E
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5364-8. PubMed ID: 6310573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques.
    Thippeshappa R; Tian B; Cleveland B; Guo W; Polacino P; Hu SL
    Clin Vaccine Immunol; 2015 Dec; 23(3):204-12. PubMed ID: 26718849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
    Moss B
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11341-8. PubMed ID: 8876137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for characterization of pathogenicity genes of recombinant DNA viruses used as human vaccines.
    Becker Y
    Virus Genes; 1987 Nov; 1(1):117-20. PubMed ID: 3508339
    [No Abstract]   [Full Text] [Related]  

  • 14. Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virus.
    Etlinger HM; Altenburger W
    Vaccine; 1991 Jul; 9(7):470-2. PubMed ID: 1716807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of recombinant vaccinia virus expressing HSV-2 gD gene as live recombinant vaccine strain].
    Yan H; Rong M; Ruan L; Hou Y; He N; Zhu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Mar; 11(1):16-20. PubMed ID: 15619895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
    Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
    J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of vaccinia virus in the development of new vaccines.
    Moss B; Fuerst TR; Flexner C; Hugin A
    Vaccine; 1988 Apr; 6(2):161-3. PubMed ID: 3291453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus: a suitable vehicle for recombinant vaccines?
    Kaplan C
    Arch Virol; 1989; 106(1-2):127-39. PubMed ID: 2669685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2.
    Flexner C; Moss B; London WT; Murphy BR
    Vaccine; 1990 Feb; 8(1):17-21. PubMed ID: 2316280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.